Sankar Swaminathan

3.3k total citations
67 papers, 1.9k citations indexed

About

Sankar Swaminathan is a scholar working on Oncology, Epidemiology and Infectious Diseases. According to data from OpenAlex, Sankar Swaminathan has authored 67 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Oncology, 25 papers in Epidemiology and 20 papers in Infectious Diseases. Recurrent topics in Sankar Swaminathan's work include Viral-associated cancers and disorders (38 papers), Cytomegalovirus and herpesvirus research (21 papers) and Parvovirus B19 Infection Studies (14 papers). Sankar Swaminathan is often cited by papers focused on Viral-associated cancers and disorders (38 papers), Cytomegalovirus and herpesvirus research (21 papers) and Parvovirus B19 Infection Studies (14 papers). Sankar Swaminathan collaborates with scholars based in United States, India and United Kingdom. Sankar Swaminathan's co-authors include Dinesh Verma, Vivian Ruvolo, Blake Tomkinson, E Kieff, Ashish Gupta, Zhao Han, Elliott Kieff, Dajiang Li, Simon Baker and M. Mathan and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and Applied Physics Letters.

In The Last Decade

Sankar Swaminathan

67 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sankar Swaminathan United States 29 1.0k 818 498 384 366 67 1.9k
J Menezes Canada 23 1.0k 1.0× 854 1.0× 427 0.9× 183 0.5× 702 1.9× 42 1.9k
Julia L. Hurwitz United States 32 636 0.6× 1.4k 1.8× 985 2.0× 573 1.5× 1.2k 3.4× 136 3.4k
Kevin Brulois United States 26 1.3k 1.3× 1.0k 1.3× 744 1.5× 643 1.7× 532 1.5× 41 2.6k
Wenshi Wang China 25 833 0.8× 594 0.7× 497 1.0× 496 1.3× 843 2.3× 74 2.4k
Grazia Galli Italy 26 771 0.8× 801 1.0× 319 0.6× 381 1.0× 2.0k 5.5× 41 3.0k
Thomas C. Shope United States 17 600 0.6× 787 1.0× 417 0.8× 84 0.2× 302 0.8× 33 1.4k
Gordon Sandford United States 22 776 0.8× 970 1.2× 494 1.0× 172 0.4× 359 1.0× 35 1.6k
Kara Bickham United States 16 644 0.6× 695 0.8× 187 0.4× 219 0.6× 1.7k 4.5× 38 2.4k
Laura Papagno France 25 383 0.4× 774 0.9× 641 1.3× 327 0.9× 2.0k 5.5× 43 3.0k
Claire Deback France 20 306 0.3× 822 1.0× 242 0.5× 100 0.3× 302 0.8× 53 1.3k

Countries citing papers authored by Sankar Swaminathan

Since Specialization
Citations

This map shows the geographic impact of Sankar Swaminathan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sankar Swaminathan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sankar Swaminathan more than expected).

Fields of papers citing papers by Sankar Swaminathan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sankar Swaminathan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sankar Swaminathan. The network helps show where Sankar Swaminathan may publish in the future.

Co-authorship network of co-authors of Sankar Swaminathan

This figure shows the co-authorship network connecting the top 25 collaborators of Sankar Swaminathan. A scholar is included among the top collaborators of Sankar Swaminathan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sankar Swaminathan. Sankar Swaminathan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jones, Barbara, et al.. (2021). Prolonged SARS-CoV-2 Illness in a Patient Receiving Ocrelizumab for Multiple Sclerosis. Open Forum Infectious Diseases. 8(7). ofab176–ofab176. 8 indexed citations
2.
Martin, Rebekah M., Dinesh Verma, Heng Xie, et al.. (2020). Contact Transmission of Vaccinia to an Infant Diagnosed by Viral Culture and Metagenomic Sequencing. Open Forum Infectious Diseases. 7(4). ofaa111–ofaa111. 5 indexed citations
3.
Li, Dajiang & Sankar Swaminathan. (2019). Human IFIT proteins inhibit lytic replication of KSHV: A new feed-forward loop in the innate immune system. PLoS Pathogens. 15(2). e1007609–e1007609. 34 indexed citations
4.
5.
Verma, Dinesh, et al.. (2016). Spironolactone blocks Epstein–Barr virus production by inhibiting EBV SM protein function. Proceedings of the National Academy of Sciences. 113(13). 3609–3614. 44 indexed citations
7.
Verma, Dinesh, Eun A Kim, & Sankar Swaminathan. (2013). Cell-Based Screening Assay for Antiviral Compounds Targeting the Ability of Herpesvirus Posttranscriptional Regulatory Proteins To Stabilize Viral mRNAs. Journal of Virology. 87(19). 10742–10751. 8 indexed citations
8.
Sudharsanam, Suchithra, Sankar Swaminathan, A. Ramalingam, et al.. (2012). Characterization of indoor bioaerosols from a hospital ward in a tropical setting. African Health Sciences. 12(2). 64 indexed citations
9.
Verma, Dinesh, et al.. (2010). Epstein-Barr Virus SM Protein Utilizes Cellular Splicing Factor SRp20 To Mediate Alternative Splicing. Journal of Virology. 84(22). 11781–11789. 47 indexed citations
10.
Verma, Dinesh & Sankar Swaminathan. (2008). Epstein-Barr Virus SM Protein Functions as an Alternative Splicing Factor. Journal of Virology. 82(14). 7180–7188. 53 indexed citations
11.
Song, Wuzhou, A. Q. Liu, Sankar Swaminathan, et al.. (2007). Determination of single living cell’s dry/water mass using optofluidic chip. Applied Physics Letters. 91(22). 29 indexed citations
12.
Nekorchuk, Michael, et al.. (2007). Kaposi's Sarcoma-Associated Herpesvirus ORF57 Protein Enhances mRNA Accumulation Independently of Effects on Nuclear RNA Export. Journal of Virology. 81(18). 9990–9998. 56 indexed citations
13.
Suck, Garnet, et al.. (2004). Epstein-Barr Virus (EBV) SM Protein Induces and Recruits Cellular Sp110b To Stabilize mRNAs and Enhance EBV Lytic Gene Expression. Journal of Virology. 78(17). 9412–9422. 49 indexed citations
14.
Swaminathan, Sankar. (2003). Molecular biology of Epstein-Barr virus and Kaposi's sarcoma-associated herpesvirus. Seminars in Hematology. 40(2). 107–115. 8 indexed citations
15.
Fleming, Jude Joseph & Sankar Swaminathan. (2001). Interference in autoanalyzer analysis. Indian Journal of Clinical Biochemistry. 16(1). 22–30. 7 indexed citations
16.
Gupta, Ashish, Vivian Ruvolo, Cam Patterson, & Sankar Swaminathan. (2000). The Human Herpesvirus 8 Homolog of Epstein-Barr Virus SM Protein (KS-SM) Is a Posttranscriptional Activator of Gene Expression. Journal of Virology. 74(2). 1038–1044. 53 indexed citations
17.
Swaminathan, Sankar. (1996). Characterization of Epstein–Barr Virus Recombinants with Deletions of theBamHI C Promoter. Virology. 217(2). 532–541. 15 indexed citations
18.
Swaminathan, Sankar, Brandon S. Huneycutt, Carol Shoshkes Reiss, & Elliott Kieff. (1992). Epstein-Barr virus-encoded small RNAs (EBERs) do not modulate interferon effects in infected lymphocytes. Journal of Virology. 66(8). 5133–5136. 50 indexed citations
19.
Jacob, Elard, Stuart Baker, & Sankar Swaminathan. (1987). ‘M’ cells in the follicle‐associated epithelium of the human colon. Histopathology. 11(9). 941–952. 31 indexed citations
20.
Baker, S. J., et al.. (1982). Chronic enterocyte infection with coronavirus. Digestive Diseases and Sciences. 27(11). 1039–1043. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026